Simian immunodeficiency virus envelope glycoprotein gp160 (SIV Env)

The Simian immunodeficiency virus (SIV) envelope glycoprotein (Env) is a trimeric type I transmembrane protein that serves as the sole viral surface antigen and is essential for viral entry into host cells (UniProt, Wikipedia). It is synthesized as a gp160 precursor that is proteolytically cleaved by host cell furin-like proteases into two non-covalently associated subunits: the surface gp120, which mediates receptor binding, and the transmembrane gp41, which facilitates membrane fusion (UniProt, NIH). SIV Env initiates infection by binding to the host CD4 receptor, which induces conformational changes that allow for subsequent interaction with a coreceptor, typically CCR5 (Wikipedia, NIH). These interactions trigger a dramatic structural rearrangement in gp41, leading to the fusion of the viral and cellular membranes and the release of the viral capsid into the cytoplasm (NIH). Due to its critical role in the viral life cycle and its exposure on the virion surface, SIV Env is a primary target for vaccine design and the development of entry inhibitors (Wikipedia, NIH). However, the protein employs sophisticated evasion strategies, including extensive N-linked glycosylation (glycan shielding) and high mutational variability, which pose significant challenges for therapeutic intervention and long-term immune control (NIH). In research settings, SIV Env is a vital model for studying HIV-1 entry mechanisms and testing novel immunotherapies, such as broadly neutralizing antibodies and fusion inhibitors (NIH, PLOS).

Other names

gp160gp120gp41Env polyproteinSurface protein gp120Transmembrane protein gp41SIV envelope protein

Inhibition of viral entry by binding to the gp120 or gp41 subunits, thereby blocking receptor/coreceptor interactions or preventing the conformational changes required for membrane fusion.